Sinopharm Capital is a private equity arm of China National Pharmaceutical Group Corporation.
Sinopharm Capital is a private equity arm of China National Pharmaceutical Group Corporation that specializes in medical and healthcare, pharmaceuticals, biotechnology, medical devices, healthcare and medical supply, and services for elderly and persons with disability. It seeks to invest in China. Sinopharm Capital was founded in June 2012 and is based in Shanghai, China.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jul 3, 2019
Synyi
|
Series C | ¥250M | Artificial Intelligence | — |
Dec 13, 2016
JoyMed Technology
|
Seed | ¥28M | Health Care | Yes |